Investor News 2008
November 04, 2008
Fresenius Medical Care Reports Strong Third Quarter and Nine Months Results; Confirms Outlook for 2008September 16, 2008
Fresenius Medical Care Announces Closing of the U.S. License Agreement for Intravenous Iron ProductsSeptember 16, 2008
Fresenius Medical Care continues to receive multiple Investor Relations awards in 2008July 30, 2008
Fresenius Medical Care Confirms Outlook for 2008; Reports Strong Second Quarter and Half Year ResultsJuly 17, 2008
Fresenius Medical Care Reports Preliminary Second Quarter and First Six Months 2008 ResultsApril 30, 2008
Fresenius Medical Care Reports Strong Start For 2008 and Confirms Outlook for Full YearApril 07, 2008
Fresenius Medical Care Announces Status in Patent CaseApril 02, 2008
Fresenius Medical Care Announces Upgraded Rating of Unsecured Debt Issues by Standard & Poor’sFebruary 22, 2008
Fresenius Medical Care Publishes Form 20-F for the Fiscal Year 2007February 20, 2008
Fresenius Medical Care Reports Excellent Fourth Quarter and Full Year 2007 Results and Provides Strong Outlook for 2008January 29, 2008
Portugal to Introduce a Bundled Rate for Hemodialysis TreatmentJanuary 25, 2008
Fresenius Medical Care Extends Senior Note Exchange OfferAwards 2008
- Thomson Extel Surveys: IR Excellence Award 2008
- Capital: Investor Relations Award 2008 for the best IR in the DAX
- Institutional Investor: Best European Investor Relations in the Healthcare Sector in 2008
- LACP: Platinum Awards for the Annual Report 2007
- IR Global Rankings: Best IR Team and TOP 1 Online Annual Report in the Industry
Awards 2007
- Thomson Extel Surveys: Best IR Work in Europe 2007
- Institutional Investor: Best European Investor Relations in the Healthcare Sector in 2007
- Capital: Investor Relations Award 2007 for the best IR in the DAX
- Manager Magazin: Best Annual Report 2007 in the DAX
- LACP: Platinum Award for the Annual Report 2006
top